Browse studies

Find your next paid study

80 recruiting studies matching your filters

Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future researc…

Cutaneous T-cell LymphomaSezary SyndromeMycosis Fungoides+2 more

Estimated

~$10 – $750

University of PittsburghNCT00177268

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

The goal of this observational study is to learn about exposure to tralokinumab during pregnancy, as well as atopic dermatitis (AD) during pregnancy. The main…

Atopic DermatitisEczema

Estimated

~$10 – $750

University of California, San DiegoNCT05938478

Phase 2

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)

The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pi…

Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more

Estimated

~$10 – $8,750

Corvus Pharmaceuticals, Inc.NCT07441395

Registry for Systemic Eczema Treatments

The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) w…

Atopic Dermatitis

Estimated

~$10 – $750

Johns Hopkins UniversityNCT06136767

Observational

Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project

This study will explore potential links between atopic dermatitis and food allergy. This information will be useful to determine atopic dermatitis and food all…

Atopic DermatitisFood AllergyHealthy

Estimated

~$10 – $6,250

University of MichiganNCT06300697

Phase 1

Phase 1b Randomized, Double Blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of LPX-TI641 in Patients With Atopic Dermatitis and Psoriasis

The goal of this clinical trial is to study the drug LPX-TI641 in patients with atopic dermatitis and psoriasis. We will compare the safety and tolerability of…

Atopic Dermatitis (AD)Psoriasis (PsO)

Estimated

~$10 – $8,750

LAPIX Therapeutics Inc.NCT06982352

Phase 2

A Multicenter Open-Label Interventional Biomarker Study of Lutikizumab in Adult Subjects With Moderate-to-Severe Hidradenitis Suppurativa or Adult Subjects With Moderate-to-Severe Atopic Dermatitis

Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflammatory skin diseases that lead to the development of skin lesions and symptoms such …

Hidradenitis SuppurativaAtopic Dermatitis

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

Our hypothesis is that S. aureus skin decolonization in atopic dermatitis reduces disease severity and favorably alters the function and gene expression of epi…

Atopic Dermatitis

Estimated

~$10 – $6,250

Boston Children's HospitalNCT06397781